SCHEMBL15976008

SCHEMBL15976008

COC(=O)c1cc(Br)nc(-c2ccc(OC)c(Cl)c2)c1N=[N+]=[N-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.40
KDM1A O60341 1/20 0.37
HDAC1 Q13547 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 4/20 0.36
KMT2A Q03164 2/20 0.36
DHODH Q02127 1/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
GAA P10253 1/20 0.34
CDK2 P24941 2/20 0.34
GSK3B P49841 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MALT1 Q9UDY8 1/20 0.34
PDE4B Q07343 2/20 0.33
HPGD P15428 1/20 0.33
GRIN2B Q13224 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15976016 0.86 MAPT (0.43) LMNAMAPTDHODHGAASMN1; SMN2
SCHEMBL15976000 0.82 TACR3 (0.41) LMNAMAPTKMT2ADHODHGAA
SCHEMBL110399 0.81 KMO (0.45) KMOLMNAMAPTKMT2ADHODH
SCHEMBL15800345 0.80 KDR (0.37) MAPTKMT2AGAAALDH1A1HPGD
SCHEMBL15976014 0.80 ALDH1A1 (0.38) MAPTTP53SMN1; SMN2ALDH1A1HPGD
SCHEMBL15800330 0.78 CA12 (0.41) LMNAMAPTKMT2ATHRBGAA
SCHEMBL15976018 0.78 PDCD1 (0.39) LMNAMAPTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL15976015 0.78 ALDH1A1 (0.34) MAPTKMT2AGAASMN1; SMN2ALDH1A1
SCHEMBL15800339 0.75 MAPT (0.41) HDAC1MAPTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL15976013 0.75 MCL1 (0.41) HDAC1KMT2ADHODHSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 US disclosed
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 US disclosed
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS JAK2, JAK1, JAK3 KMO 565/4885KDM1A 533/4885HDAC1 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.